Pronounced adipogenesis and increased insulin sensitivity caused by overproduction of prostaglandin D2in vivo

FEBS Journal

Volumn 277, Issue 6, 2010, Pages 1410-1419

  Fujitani, Yasushi ^a,e   Aritake, Kosuke ^a   Kanaoka, Yoshihide ^a,b   Goto, Tsuyoshi ^c   Takahashi, Nobuyuki ^c   Fujimori, Ko ^a,d   Kawada, Teruo ^c  

^a OSAKA BIOSCIENCE INSTITUTE   (Japan)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c KYOTO UNIVERSITY   (Japan)

^d OSAKA MEDICAL COLLEGE   (Japan)

^e TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

Adipocytes; H PGDS; Obesity; PGD2; Transgenic mouse

Indexed keywords

BETA ACTIN; FATTY ACID BINDING PROTEIN 4; INSULIN; LEPTIN; LIPOCALIN; LIPOPROTEIN LIPASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN D SYNTHASE; PROSTAGLANDIN D2; RETINOID; TRIACYLGLYCEROL;

ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BROWN ADIPOSE TISSUE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENETIC TRANSCRIPTION; GLUCOSE TOLERANCE; HYPOGLYCEMIA; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID DIET; LIPOPHILICITY; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; WHITE ADIPOSE TISSUE; WILD TYPE;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CELL DIFFERENTIATION; DIABETES MELLITUS, EXPERIMENTAL; DIETARY FATS; FEMALE; HUMANS; MALE; MICE; MICE, TRANSGENIC; OBESITY; PROSTAGLANDIN D2; UP-REGULATION;

MUS; MUS MUSCULUS;

EID: 77749316918     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2010.07565.x     Document Type: Article

References (48)

1. Spiegelman BM Flier JS (2001) Obesity and the regulation of energy balance. Cell 104, 531 543.
2. Fujimori K, Aritake K Urade Y (2007) A novel pathway to enhance adipocyte differentiation of 3T3-L1 cells by up-regulation of lipocalin-type prostaglandin D synthase mediated by liver X receptor-activated sterol regulatory element-binding protein-1c. J Biol Chem 282, 18458 18466.
3. Casimir DA, Miller CW Ntambi JM (1996) Preadipocyte differentiation blocked by prostaglandin stimulation of prostanoid FP2 receptor in murine 3T3-L1 cells. Differentiation 60, 203 210.
4. Miller CW, Casimir DA Ntambi JM (1996) The mechanism of inhibition of 3T3-L1 preadipocyte differentiation by prostaglandin F2alpha. Endocrinology 137, 5641 5650.
5. Tsuboi H, Sugimoto Y, Kainoh T Ichikawa A (2004) Prostanoid EP4 receptor is involved in suppression of 3T3-L1 adipocyte differentiation. Biochem Biophys Res Commun 322, 1066 1072.
6. Urade Y Hayaishi O (2000) Prostaglandin D synthase: structure and function. Vitam Horm 58, 89 120.
7. Christ-Hazelhof E Nugteren DH (1979) Purification and characterisation of prostaglandin endoperoxide D-isomerase, a cytoplasmic, glutathione-requiring enzyme. Biochim Biophys Acta 572, 43 51.
8. Urade Y, Fujimoto N, Ujihara M Hayaishi O (1987) Biochemical and immunological characterization of rat spleen prostaglandin D synthetase. J Biol Chem 262, 3820 3825.
9. Murakami M, Matsumoto R, Urade Y, Austen KF Arm JP (1995) c-kit ligand mediates increased expression of cytosolic phospholipase A2, prostaglandin endoperoxide synthase-1, and hematopoietic prostaglandin D2 synthase and increased IgE-dependent prostaglandin D2 generation in immature mouse mast cells. J Biol Chem 270, 3239 3246.
10. Urade Y, Ujihara M, Horiguchi Y, Igarashi M, Nagata A, Ikai K Hayaishi O (1990) Mast cells contain spleen-type prostaglandin D synthetase. J Biol Chem 265, 371 375.
11. Urade Y, Ujihara M, Horiguchi Y, Ikai K Hayaishi O (1989) The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. J Immunol 143, 2982 2989.
12. Fujimori K, Kanaoka Y, Sakaguchi Y Urade Y (2000) Transcriptional activation of the human hematopoietic prostaglandin D synthase gene in megakaryoblastic cells. Roles of the Oct-1 element in the 5′-flanking region and the AP-2 element in the untranslated exon 1. J Biol Chem 275, 40511 40516.
13. Mahmud I, Ueda N, Yamaguchi H, Yamashita R, Yamamoto S, Kanaoka Y, Urade Y Hayaishi O (1997) Prostaglandin D synthase in human megakaryoblastic cells. J Biol Chem 272, 28263 28266.
14. Tanaka K, Ogawa K, Sugamura K, Nakamura M, Takano S Nagata K (2000) Cutting edge: differential production of prostaglandin D2 by human helper T cell subsets. J Immunol 164, 2277 2280.
15. Kanaoka Y Urade Y (2003) Hematopoietic prostaglandin D synthase. Prostaglandins Leukot Essent Fatty Acids 69, 163 167.
16. Aritake K, Kado Y, Inoue T, Miyano M Urade Y (2006) Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase. J Biol Chem 281, 15277 15286.
17. Hayes JD, Flanagan JU Jowsey IR (2005) Glutathione transferases. Annu Rev Pharmacol Toxicol 45, 51 88.
18. Urade Y, Fujimoto N Hayaishi O (1985) Purification and characterization of rat brain prostaglandin D synthetase. J Biol Chem 260, 12410 12415.
19. Jowsey IR, Murdock PR, Moore GB, Murphy GJ, Smith SA Hayes JD (2003) Prostaglandin D2 synthase enzymes and PPARgamma are co-expressed in mouse 3T3-L1 adipocytes and human tissues. Prostaglandins Other Lipid Mediat 70, 267 284.
20. Quinkler M, Bujalska IJ, Tomlinson JW, Smith DM Stewart PM (2006) Depot-specific prostaglandin synthesis in human adipose tissue: a novel possible mechanism of adipogenesis. Gene 380, 137 143.
21. Urade Y Hayaishi O (2000) Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase. Biochim Biophys Acta 1482, 259 271.
22. Xie Y, Kang X, Ackerman WE, Belury MA, Koster C, Rovin BH, Landon MB Kniss DA (2006) Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins. Diabetes Obes Metab 8, 83 93.
23. Urade Y Aritake K (2007) Multifunctional Properties of Lipocalin-type Prostaglandin D Synthase. Research Signpost, Kerala.
24. Urade Y Eguchi N (2002) Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence. Prostaglandins Other Lipid Mediat 68-69, 375 382.
25. Tanaka T, Urade Y, Kimura H, Eguchi N, Nishikawa A Hayaishi O (1997) Lipocalin-type prostaglandin D synthase (beta-trace) is a newly recognized type of retinoid transporter. J Biol Chem 272, 15789 15795.
26. Beuckmann CT, Aoyagi M, Okazaki I, Hiroike T, Toh H, Hayaishi O Urade Y (1999) Binding of biliverdin, bilirubin, and thyroid hormones to lipocalin-type prostaglandin D synthase. Biochemistry 38, 8006 8013.
27. Mohri I, Taniike M, Okazaki I, Kagitani-Shimono K, Aritake K, Kanekiyo T, Yagi T, Takikita S, Kim HS, Urade Y et al. (2006) Lipocalin-type prostaglandin D synthase is up-regulated in oligodendrocytes in lysosomal storage diseases and binds gangliosides. J Neurochem 97, 641 651.
28. Kanekiyo T, Ban T, Aritake K, Huang ZL, Qu WM, Okazaki I, Mohri I, Murayama S, Ozono K, Taniike M et al. (2007) Lipocalin-type prostaglandin D synthase/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid. Proc Natl Acad Sci USA 104, 6412 6417.
29. Ragolia L, Palaia T, Hall CE, Maesaka JK, Eguchi N Urade Y (2005) Accelerated glucose intolerance, nephropathy, and atherosclerosis in prostaglandin D2 synthase knock-out mice. J Biol Chem 280, 29946 29955.
30. Tanaka R, Miwa Y, Mou K, Tomikawa M, Eguchi N, Urade Y, Takahashi-Yanaga F, Morimoto S, Wake N Sasaguri T (2009) Knockout of the l-pgds gene aggravates obesity and atherosclerosis in mice. Biochem Biophys Res Commun 378, 851 856.
31. Kang S, Bajnok L, Longo KA, Petersen RK, Hansen JB, Kristiansen K MacDougald OA (2005) Effects of Wnt signaling on brown adipocyte differentiation and metabolism mediated by PGC-1alpha. Mol Cell Biol 25, 1272 1282.
32. Rosen ED (2005) The transcriptional basis of adipocyte development. Prostaglandins Leukot Essent Fatty Acids 73, 31 34.
33. Ragolia L, Hall CE Palaia T (2008) Lipocalin-type prostaglandin D(2) synthase stimulates glucose transport via enhanced GLUT4 translocation. Prostaglandins Other Lipid Mediat 87, 34 41.
34. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM Evans RM (1995) 15-Deoxy-delta12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83, 803 812.
35. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC Lehmann JM (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83, 813 819.
36. Bell-Parikh LC, Ide T, Lawson JA, McNamara P, Reilly M FitzGerald GA (2003) Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. J Clin Invest 112, 945 955.
37. Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K, Ide T, Kubota N, Terauchi Y, Tobe K et al. (2001) The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J Biol Chem 276, 41245 41254.
38. Jowsey IR, Thomson AM, Flanagan JU, Murdock PR, Moore GB, Meyer DJ, Murphy GJ, Smith SA Hayes JD (2001) Mammalian class Sigma glutathione S-transferases: catalytic properties and tissue-specific expression of human and rat GSH-dependent prostaglandin D2 synthases. Biochem J 359, 507 516.
39. Evans-Molina C, Robbins RD, Kono T, Tersey SA, Vestermark GL, Nunemaker CS, Garmey JC, Deering TG, Keller SR, Maier B et al. (2009) Peroxisome proliferator-activated receptor gamma activation restores islet function in diabetic mice through reduction of endoplasmic reticulum stress and maintenance of euchromatin structure. Mol Cell Biol 29, 2053 2067.
40. Wajchenberg BL (2007) Beta-cell failure in diabetes and preservation by clinical treatment. Endocr Rev 28, 187 218.
41. Yildirim S, Bolkent S Sundler F (2008) The role of rosiglitazone treatment in the modulation of islet hormones and hormone-like peptides: a combined in situ hybridization and immunohistochemical study. J Mol Histol 39, 635 642.
42. Speakman J, Hambly C, Mitchell S Krol E (2008) The contribution of animal models to the study of obesity. Lab Anim 42, 413 432.
43. Niwa H, Yamamura K Miyazaki J (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193 199.
44. Fujimori K, Kadoyama K Urade Y (2005) Protein kinase C activates human lipocalin-type prostaglandin D synthase gene expression through de-repression of Notch-Hes signaling and enhancement of AP-2 beta function in brain-derived TE671 cells. J Biol Chem 280, 18452 18461.
45. Kanaoka Y, Fujimori K, Kikuno R, Sakaguchi Y, Urade Y Hayaishi O (2000) Structure and chromosomal localization of human and mouse genes for hematopoietic prostaglandin D synthase. Conservation of the ancestral genomic structure of sigma-class glutathione S-transferase. Eur J Biochem 267, 3315 3322.
46. Fujitani Y, Kanaoka Y, Aritake K, Uodome N, Okazaki-Hatake K Urade Y (2002) Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice. J Immunol 168, 443 449.
47. Pinzar E, Kanaoka Y, Inui T, Eguchi N, Urade Y Hayaishi O (2000) Prostaglandin D synthase gene is involved in the regulation of non-rapid eye movement sleep. Proc Natl Acad Sci USA 97, 4903 4907.
48. Ohyama M, Matsuda K, Torii S, Matsui T, Yano H, Kawada T Ishihara T (1998) The interaction between vitamin A and thiazolidinedione on bovine adipocyte differentiation in primary culture. J Anim Sci 76, 61 65.